Table 2 Association of annual mean maximum daily 8-h O3 concentrations from the previous year (1-year moving average) with ESRD and all-cause mortality in participants with CKD

Model

 Age

1

0.999

1.002

1

0.998

1.003

1.068

1.066

1.07

1.06

1.057

1.063

 Male

1.406

1.349

1.465

1.365

1.264

1.475

1.72

1.651

1.792

1.827

1.706

1.957

 Hypertension

0.958

0.915

1.003

0.863

0.785

0.949

1.141

1.093

1.192

1.594

1.483

1.713

 Diabetic Mellitus

2.629

2.517

2.747

2.371

2.187

2.571

1.524

1.462

1.588

1.409

1.315

1.509

 BMI < 18.5

0.266

0.25

0.282

0.289

0.257

0.324

0.745

0.709

0.782

0.879

0.812

0.952

 23 ≤ BMI < 25

0.628

0.593

0.665

0.634

0.57

0.705

0.605

0.57

0.642

0.571

0.517

0.63

 25 \(\le\) BMI

0.552

0.524

0.581

0.578

0.524

0.636

0.526

0.496

0.557

0.419

0.379

0.463

 O3 (ppb)

1.034

1.031

1.036

1.019

1.011

1.026

1.02

1.018

1.023

1.047

1.041

1.054

Model1

 Age

0.986

0.985

0.988

0.986

0.984

0.989

1.059

1.057

1.06

1.051

1.048

1.054

 Male

1.214

1.165

1.265

1.212

1.122

1.309

1.608

1.544

1.675

1.701

1.589

1.821

 Hypertension

0.963

0.92

1.008

0.8

0.728

0.879

1.142

1.094

1.193

1.576

1.467

1.693

 Diabetic Mellitus

1.71

1.638

1.785

1.67

1.543

1.808

1.304

1.251

1.359

1.236

1.154

1.324

 BMI < 18.5

0.458

0.43

0.487

0.436

0.388

0.491

0.951

0.906

0.999

1.075

0.992

1.165

 23 ≤ BMI < 25

0.842

0.795

0.891

0.879

0.79

0.978

0.677

0.637

0.719

0.642

0.581

0.709

 25 \(\le\) BMI

0.799

0.759

0.842

0.889

0.806

0.981

0.608

0.574

0.644

0.481

0.435

0.533

 e-GFR(mL/min/1.73 m²)

0.929

0.928

0.931

0.927

0.925

0.929

0.972

0.971

0.973

0.974

0.973

0.976

 O3 (ppb)

1.025

1.023

1.028

1.02

1.013

1.028

1.016

1.014

1.019

1.046

1.039

1.053

Model2

 Age

0.987

0.986

0.988

0.987

0.984

0.99

1.06

1.058

1.061

1.05

1.047

1.053

 Male

1.216

1.165

1.269

1.193

1.097

1.297

1.591

1.524

1.66

1.671

1.553

1.798

 Hypertension

0.929

0.887

0.974

0.778

0.705

0.858

1.077

1.03

1.126

1.537

1.427

1.656

 Diabetic Mellitus

1.683

1.61

1.76

1.673

1.535

1.823

1.269

1.215

1.325

1.165

1.082

1.255

 BMI < 18.5

0.489

0.458

0.522

0.449

0.394

0.512

0.915

0.869

0.964

1.017

0.932

1.109

 23 ≤ BMI < 25

0.845

0.796

0.896

0.892

0.794

1.003

0.665

0.625

0.708

0.632

0.569

0.702

 25 \(\le\) BMI

0.778

0.737

0.822

0.866

0.779

0.962

0.599

0.564

0.636

0.458

0.411

0.509

 e-GFR(mL/min/1.73 m²)

0.927

0.926

0.928

0.922

0.92

0.925

0.972

0.971

0.973

0.975

0.973

0.976

 O3 (ppb)

1.049

1.044

1.054

1.023

1.013

1.033

1.015

1.01

1.019

1.048

1.04

1.057

 NO2(ppb)

1.017

1.013

1.02

0.992

0.983

1.001

1.006

1.003

1.01

1.019

1.012

1.026

Model3

 Age

0.987

0.986

0.989

0.987

0.984

0.989

1.06

1.058

1.062

1.051

1.048

1.054

 Male

1.219

1.168

1.272

1.191

1.096

1.295

1.594

1.527

1.664

1.678

1.56

1.806

 Hypertension

0.926

0.883

0.971

0.786

0.712

0.867

1.074

1.027

1.124

1.538

1.428

1.657

 Diabetic Mellitus

1.676

1.603

1.753

1.675

1.537

1.825

1.269

1.215

1.325

1.168

1.085

1.258

 BMI < 18.5

0.493

0.462

0.526

0.452

0.396

0.514

0.912

0.865

0.961

1.014

0.929

1.106

 23 ≤ BMI < 25

0.843

0.795

0.895

0.893

0.794

1.003

0.662

0.622

0.705

0.633

0.57

0.702

 25 \(\le\) BMI

0.778

0.737

0.821

0.865

0.779

0.962

0.601

0.566

0.638

0.461

0.414

0.513

 e-GFR(mL/min/1.73 m²)

0.927

0.926

0.928

0.922

0.92

0.925

0.972

0.971

0.973

0.975

0.973

0.977

 O3 (ppb)

1.049

1.044

1.054

1.025

1.014

1.035

1.012

1.008

1.017

1.04

1.031

1.05

 NO2(ppb)

1.016

1.012

1.02

0.991

0.982

1

1.004

1

1.008

1.025

1.018

1.033

 Beds in medical facilities per 1,000 people

1.003

0.997

1.01

1.012

1

1.025

0.979

0.973

0.985

0.992

0.982

1.002

 Financial independence

1.001

1

1.003

1

0.997

1.003

0.999

0.998

1.001

0.995

0.992

0.998